# Tango Therapeutics, Inc.: Form 8-K, filed Feb 27, 2025

- Company: [Tango Therapeutics, Inc.](/companies/tngx.md) (CIK 1819133)
- Form: 8-K
- Filed: 2025-02-27
- Accepted by EDGAR: Feb 27, 2025, 12:06 ET
- Period: 2022-08-10
- Accession: 0000950170-25-028345
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819133/000095017025028345/tngx-20220810.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819133/000095017025028345/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819133/000095017025028345/tngx-20220810.htm

Filed Feb 27, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-028345. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.